NONABLATIVE AND ABLATIVE TISSUE TREATMENT METHOD AND DEVICE
Methods and devices for treatment of tissue which first apply a nonablative form of electromagnetic energy to a region of tissue to create a plurality of treatment zones containing coagulated tissue and subsequently apply an ablative form of electromagnetic energy to the coagulated tissue in the treatment zones in order to ablate the coagulated tissue are disclosed. These methods and devices can be used to shrink and/or tighten tissue for medical and cosmetic purposes.
1 . A method of treating tissue comprising:
selecting a region of tissue in need of tightening;
first, treating the region of tissue using a first form of electromagnetic energy in a manner so as to coagulate tissue within a plurality of treatment zones in the region of tissue; and
second, treating the region of tissue using a second form of electromagnetic energy in a manner so as to ablate at least a portion of the coagulated tissue from within at least a portion of the plurality of treatment zones in the region of tissue while leaving uncoagulated tissue substantially unablated,
wherein the first and second treating tighten the region of tissue.
2 . The method of claim 1 , wherein the first and second forms of electromagnetic energy are the same form of electromagnetic radiation.
3 . The method of claim 1 , wherein the first and second forms of electromagnetic energy are different forms of electromagnetic radiation.
4 . The method of claim 1 , wherein the first form of electromagnetic energy is nonablative and the second form of electromagnetic energy is ablative.
5 . The method of claim 1 , wherein the first and second forms of electromagnetic energy are both forms of optical energy.
6 . The method of claim 1 , wherein the first and second forms of electromagnetic energy are both forms of laser radiation.
7 . The method of claim 1 , wherein the first and second forms of electromagnetic energy are different wavelengths of laser radiation.
8 . The method of claim 1 , wherein the second treating is performed immediately following the first treating.
9 . The method of claim 1 , wherein the second treating is performed prior to healing of the first treating.
10 . The method of claim 1 , wherein the first treating comprises more than one electromagnetic energy treating.
11 . The method of claim 1 , wherein the second treating comprises more than one electromagnetic energy treating.
12 . The method of claim 1 , wherein the method further comprises the step of detecting coagulated tissue in the plurality of treatment zones.
13 . The method of claim 1 , wherein the method further comprises the step of determining the location of coagulated tissue in the region of tissue.
14 . The method of claim 1 , wherein the tissue is skin.
15 . The method of claim 14 , wherein the first treating coagulates at least a portion of the epidermis, and the second treating ablates at least a portion of coagulated epidermis within at least a portion of the treatment zones in the region of tissue.
16 . The method of claim 14 , wherein the first treating coagulates at least a portion of the dermis, and the second treating ablates at least a portion of coagulated dermis within at least a portion of the treatment zones in the region of tissue.
17 . The method of claim 1 , wherein the first optical energy treatment is produced by a laser selected from the group consisting of an argon ion gas laser, a carbon dioxide (CO 2 ) gas laser, an excimer chemical laser, a dye laser, a neodymium yttrium aluminum garnet (Nd:YAG) laser, an erbium yttrium aluminum garnet (Er:YAG) laser, a holmium yttrium aluminum garnet (Ho:YAG) laser, an alexandrite laser, an erbium doped glass laser, a neodymium doped glass laser, a thulium doped glass laser, an erbium-ytterbium co-doped glass laser, an erbium doped fiber laser, a neodymium doped fiber laser, a thulium doped fiber laser, an erbium-ytterbium co-doped fiber laser, and combinations thereof.
18 . The method of claim 1 , wherein the second optical energy treatment is produced by a laser selected from the group consisting of an argon ion gas laser, a carbon dioxide (CO 2 ) gas laser, an excimer chemical laser, a dye laser, a neodymium yttrium aluminum garnet (Nd:YAG) laser, an erbium yttrium aluminum garnet (Er:YAG) laser, a holmium yttrium aluminum garnet (Ho:YAG) laser, an alexandrite laser, an erbium doped glass laser, a neodymium doped glass laser, a thulium doped glass laser, an erbium-ytterbium co-doped glass laser, an erbium doped fiber laser, a neodymium doped fiber laser, a thulium doped fiber laser, an erbium-ytterbium co-doped fiber laser, and combinations thereof.
19 . A device for tightening tissue, comprising:
a first electromagnetic energy source for providing a first electromagnetic energy treatment configured to apply the first electromagnetic energy treatment to a region of tissue in a manner so as to thermally coagulate tissue in a plurality of treatment zones in the region of tissue;
a second electromagnetic energy source for providing a second electromagnetic energy treatment configured to apply the second electromagnetic energy treatment to at least a portion of the plurality of treatment zones in the region of tissue and to thereby ablate at least a portion of the thermally coagulated tissue within;
a controller configured to control the first and second electromagnetic energy sources; and
a detector configured to detect the location and/or presence of coagulated tissue in the region of tissue and to provide feedback to the controller,
wherein the controller is configured to use the feedback from the detector to determine when and how to apply the second electromagnetic energy to ablate at least a portion of coagulated tissue in a treatment zone.
20 . The device of claim 19 , wherein the first and second electromagnetic energy sources are optical energy sources.
21 . The device of claim 19 , wherein the first and second electromagnetic energy sources are laser sources.
22 . The device of claim 20 , wherein a beam size of the first optical source is larger than a beam size of the second optical energy source when the beams impact the region tissue.
23 . The device of claim 20 , wherein a beam size of the first optical source is smaller than a beam size of the second optical energy source when the beams impact the region tissue.
24 . The device of claim 20 , wherein a beam size of the first and second optical energy sources are approximately equal when the beams impact the region of tissue.
25 . The device of claim 20 , wherein a beam size of the first optical energy source is between about 30 μm and about 2 mm.
26 . The device of claim 20 , wherein a beam size of the first optical energy source is between about 50 μm and about 1000 μm.
27 . The device of claim 20 , wherein a beam size of the first optical energy source is between about 100 μm and about 500 μm.
28 . The device of claim 20 , wherein a beam size of the second optical energy source is between about 30 μm and about 2 mm.
29 . The device of claim 20 , wherein a beam size of the second optical energy source is between about 50 μm and about 1000 μm.
30 . The device of claim 20 , wherein a beam size of the second optical energy source is between about 100 μm and about 500 μm.
31 . The device of claim 20 , wherein the wavelength of both the first optical energy source and the second optical energy source is between about 1,200 nm and about 20,000 nm.
32 . The device of claim 20 , wherein the wavelength of both the first optical energy source is strongly absorbed by water.
33 . The device of claim 20 , wherein the wavelength of the first optical energy source is in the near infrared spectrum.
34 . The device of claim 20 , wherein the wavelength of the first optical energy source is between about 700 nm and about 1400 nm.
35 . The device of claim 20 , wherein the first optical energy source is an erbium fiber laser and the second optical energy source is a carbon dioxide laser.